First Time Loading...

Merck & Co Inc
NYSE:MRK

Watchlist Manager
Merck & Co Inc Logo
Merck & Co Inc
NYSE:MRK
Watchlist
Price: 125.78 USD 0.44% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. [ Read More ]

The intrinsic value of one MRK stock under the Base Case scenario is 135.96 USD. Compared to the current market price of 125.78 USD, Merck & Co Inc is Undervalued by 7%.

Key Points:
MRK Intrinsic Value
Base Case
135.96 USD
Undervaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Merck & Co Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling MRK stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Merck & Co Inc

Provide an overview of the primary business activities
of Merck & Co Inc.

What unique competitive advantages
does Merck & Co Inc hold over its rivals?

What risks and challenges
does Merck & Co Inc face in the near future?

Has there been any significant insider trading activity
in Merck & Co Inc recently?

Summarize the latest earnings call
of Merck & Co Inc.

What significant events have occurred
in Merck & Co Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Merck & Co Inc.

Provide P/S
for Merck & Co Inc.

Provide P/E
for Merck & Co Inc.

Provide P/OCF
for Merck & Co Inc.

Provide P/FCFE
for Merck & Co Inc.

Provide P/B
for Merck & Co Inc.

Provide EV/S
for Merck & Co Inc.

Provide EV/GP
for Merck & Co Inc.

Provide EV/EBITDA
for Merck & Co Inc.

Provide EV/EBIT
for Merck & Co Inc.

Provide EV/OCF
for Merck & Co Inc.

Provide EV/FCFF
for Merck & Co Inc.

Provide EV/IC
for Merck & Co Inc.

Show me price targets
for Merck & Co Inc made by professional analysts.

What are the Revenue projections
for Merck & Co Inc?

How accurate were the past Revenue estimates
for Merck & Co Inc?

What are the Net Income projections
for Merck & Co Inc?

How accurate were the past Net Income estimates
for Merck & Co Inc?

What are the EPS projections
for Merck & Co Inc?

How accurate were the past EPS estimates
for Merck & Co Inc?

What are the EBIT projections
for Merck & Co Inc?

How accurate were the past EBIT estimates
for Merck & Co Inc?

Compare the revenue forecasts
for Merck & Co Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Merck & Co Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Merck & Co Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Merck & Co Inc compared to its peers.

Compare the P/E ratios
of Merck & Co Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Merck & Co Inc with its peers.

Analyze the financial leverage
of Merck & Co Inc compared to its main competitors.

Show all profitability ratios
for Merck & Co Inc.

Provide ROE
for Merck & Co Inc.

Provide ROA
for Merck & Co Inc.

Provide ROIC
for Merck & Co Inc.

Provide ROCE
for Merck & Co Inc.

Provide Gross Margin
for Merck & Co Inc.

Provide Operating Margin
for Merck & Co Inc.

Provide Net Margin
for Merck & Co Inc.

Provide FCF Margin
for Merck & Co Inc.

Show all solvency ratios
for Merck & Co Inc.

Provide D/E Ratio
for Merck & Co Inc.

Provide D/A Ratio
for Merck & Co Inc.

Provide Interest Coverage Ratio
for Merck & Co Inc.

Provide Altman Z-Score Ratio
for Merck & Co Inc.

Provide Quick Ratio
for Merck & Co Inc.

Provide Current Ratio
for Merck & Co Inc.

Provide Cash Ratio
for Merck & Co Inc.

What is the historical Revenue growth
over the last 5 years for Merck & Co Inc?

What is the historical Net Income growth
over the last 5 years for Merck & Co Inc?

What is the current Free Cash Flow
of Merck & Co Inc?

Financials

Balance Sheet Decomposition
Merck & Co Inc

Current Assets 32.2B
Cash & Short-Term Investments 7.1B
Receivables 11.1B
Other Current Assets 14B
Non-Current Assets 74.5B
Long-Term Investments 1.5B
PP&E 23.1B
Intangibles 39.2B
Other Non-Current Assets 10.7B
Current Liabilities 25.7B
Accounts Payable 3.9B
Accrued Liabilities 15.2B
Other Current Liabilities 6.6B
Non-Current Liabilities 43.4B
Long-Term Debt 33.7B
Other Non-Current Liabilities 9.7B
Efficiency

Earnings Waterfall
Merck & Co Inc

Revenue
60.1B USD
Cost of Revenue
-15.9B USD
Gross Profit
44.2B USD
Operating Expenses
-40.1B USD
Operating Income
4.1B USD
Other Expenses
-3.7B USD
Net Income
365m USD

Free Cash Flow Analysis
Merck & Co Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

MRK Profitability Score
Profitability Due Diligence

Merck & Co Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Year Average ROE
Positive Operating Income
59/100
Profitability
Score

Merck & Co Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

MRK Solvency Score
Solvency Due Diligence

Merck & Co Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
45/100
Solvency
Score

Merck & Co Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MRK Price Targets Summary
Merck & Co Inc

Wall Street analysts forecast MRK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRK is 139.76 USD with a low forecast of 119.18 USD and a high forecast of 155.4 USD.

Lowest
Price Target
119.18 USD
5% Downside
Average
Price Target
139.76 USD
11% Upside
Highest
Price Target
155.4 USD
24% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

MRK Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

MRK Price
Merck & Co Inc

1M 1M
+2%
6M 6M
+23%
1Y 1Y
+10%
3Y 3Y
+79%
5Y 5Y
+103%
10Y 10Y
+204%
Annual Price Range
125.78
52w Low
100.18
52w High
131.95
Price Metrics
Average Annual Return 17.74%
Standard Deviation of Annual Returns 26.05%
Max Drawdown -27%
Shares Statistics
Market Capitalization 318.4B USD
Shares Outstanding 2 533 029 888
Percentage of Shares Shorted 0.77%

MRK Return Decomposition
Main factors of price return

What is price return decomposition?

MRK News

Other Videos

Last Important Events
Merck & Co Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Merck & Co Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Merck & Co Inc Logo
Merck & Co Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

318.4B USD

Dividend Yield

2.45%

Description

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Kenilworth, New Jersey and currently employs 68,000 full-time employees. The firm offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. The company operates through two segments: Pharmaceutical and Animal Health. The firm's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The firm sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species.

Contact

NEW JERSEY
Kenilworth
2000 Galloping Hill Rd
+19087404000.0
https://www.merck.com/

IPO

1941-01-01

Employees

68 000

Officers

Chairman, President & CEO
Mr. Robert M. Davis J.D.
Executive VP & CFO
Ms. Caroline Litchfield
Executive VP & General Counsel
Ms. Jennifer L. Zachary
Executive VP & President of Merck Research Laboratories
Dr. Dean Y. Li M.D., Ph.D.
Senior VP & Chief Marketing Officer of Human Health
Mr. Chirfi Guindo
Senior VP of Finance, Principal Accounting Officer & Global Controller
Mr. Dalton E. Smart III
Show More
Executive VP and Chief Information & Digital Officer
Mr. David Michael Williams
Vice President of Investor Relations
Mr. Peter Dannenbaum
Senior VP and Chief Ethics & Compliance Officer
Lisa LeCointe-Cephas
Executive VP and Chief Communications & Public Affairs Officer
Ms. Cristal N. Downing
Show Less

See Also

Discover More
What is the Intrinsic Value of one MRK stock?

The intrinsic value of one MRK stock under the Base Case scenario is 135.96 USD.

Is MRK stock undervalued or overvalued?

Compared to the current market price of 125.78 USD, Merck & Co Inc is Undervalued by 7%.